输精管结扎术与前列腺癌风险关联的荟萃分析
该荟萃分析系统检索了PubMed、Cochrane Library和EMBASE数据库(截至2021年3月14日),纳入58项研究共16,989,237名参与者,评估输精管结扎术与前列腺癌风险的关联。结果显示输精管结扎术与任何前列腺癌风险显著相关(RR=1.18,95%CI 1.07-1.31),与晚期前列腺癌、低级别和中级別前列腺癌也显著相关,但与前列腺癌特异性死亡率无显著关联。作者建议在输精管结扎术前充分告知患者前列腺癌风险。
要点
- 输精管结扎术与任何前列腺癌风险显著相关(RR=1.18,95%CI 1.07-1.31)。
- 输精管结扎术与晚期前列腺癌风险显著相关(RR=1.06,95%CI 1.01-1.12)。
- 输精管结扎术与前列腺癌特异性死亡率无显著关联(RR=1.01,95%CI 0.93-1.10)。
核心结论
- 输精管结扎术与任何前列腺癌及晚期前列腺癌风险显著相关,但与前列腺癌特异性死亡率无显著关联。
研究设计与样本
- 系统检索PubMed、Cochrane Library和EMBASE数据库(从建库至2021年3月14日),无年份或语言限制,纳入58项研究共16,989,237名参与者,使用多变量调整风险比(RR)评估终点,采用Newcastle-Ottawa量表评估偏倚风险。
主要发现
- 输精管结扎术与任何前列腺癌风险显著相关(RR=1.18,95%CI 1.07-1.31)。
- 输精管结扎术与晚期前列腺癌风险显著相关(RR=1.06,95%CI 1.01-1.12)。
- 输精管结扎术与低级别前列腺癌风险显著相关(RR=1.06,95%CI 1.02-1.10)。
- 输精管结扎术与中级別前列腺癌风险显著相关(RR=1.12,95%CI 1.03-1.22)。
- 输精管结扎术与前列腺癌特异性死亡率无显著关联(RR=1.01,95%CI 0.93-1.10)。
临床怎么用
- 在输精管结扎术前应充分告知患者前列腺癌风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The debate over the association between vasectomy and prostate cancer has been lasted about 40 years and there is no sign of stopping. In the present study, we aimed to evaluate whether vasectomy is associated with prostate cancer based on the most comprehensive and up-to-date evidence available. METHODS: The PubMed, Cochrane Library, and EMBASE databases were systematically searched inception to March 14, 2021 without year or language restriction. Multivariable adjusted risk ratios (RRs) were used to assess each endpoint. Risk of bias was assessed using the Newcastle-Ottawa scale. RESULTS: A total of 58 studies involving 16,989,237 participants fulfilled inclusion criteria. There was significant association of vasectomy with risk of any prostate cancer (risk ratio, 1.18, 95% CI, 1.07-1.31). Association between vasectomy and advanced prostate cancer (risk ratio, 1.06, 95% CI, 1.01-1.12), low-grade prostate cancer (risk ratio, 1.06, 95% CI, 1.02-1.10), and intermediate-grade prostate cancer (risk ratio, 1.12, 95% CI, 1.03-1.22) were significant. There was no significant association between vasectomy and prostate cancer-specific mortality (risk ratio, 1.01, 95% CI, 0.93-1.10). CONCLUSIONS: This study found that vasectomy was associated with the risk of any prostate cancer and advanced prostate cancer. From the current evidence, patients should be fully informed of the risk of prostate cancer before vasectomy.
引用
- Xu Y, Li L, Yang W, et al. Association between vasectomy and risk of prostate cancer: a meta-analysis. Prostate Cancer Prostatic Dis. 2021. PMID: 33927357. doi:10.1038/s41391-021-00368-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。